Low serum levels of high-density lipoprotein cholesterol and hypolipidaemic treatment

Curr Med Res Opin. 2002;18(5):265-8. doi: 10.1185/030079902125000534.

Abstract

Low serum levels of high-density lipoprotein (HDL) cholesterol is an independent risk factor for coronary artery disease. Raising HDL cholesterol should be an important therapeutic goal in patients with coronary artery disease. Fibrates can reduce the risk of cardiac events and death from coronary artery disease.

Publication types

  • Review

MeSH terms

  • Cholesterol, LDL / blood*
  • Coronary Disease / blood
  • Coronary Disease / prevention & control*
  • Gemfibrozil / pharmacology*
  • Humans
  • Hyperlipidemias / drug therapy*
  • Hypolipidemic Agents / pharmacology*
  • Risk Factors

Substances

  • Cholesterol, LDL
  • Hypolipidemic Agents
  • Gemfibrozil